An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT04189614 · TERMINATED
Trial details
- NCT number
- NCT04189614
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2026-05-07
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.